Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1818 USD | +0.55% | -5.31% | -15.91% |
Mar. 27 | Transcript : Matinas BioPharma Holdings, Inc., 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.91% | 45.6M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.40% | 22.2B | |
-16.53% | 21.23B | |
-9.35% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- MTNB Stock
- News Matinas BioPharma Holdings, Inc.
- Matinas BioPharma : Receives Award of Up to $3.75 Million to Support Development of Drug Candidate MAT2501